logo
Sign in

MNK Stock Price, Chart, Stats & News

Mallinckrodt plc
Save
4.52M
Market cap
Current P/E
Forward P/E

MNK chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
41.23%
Operating margin
-8.29%
Pretax margin
12.31%
Net margin
8.64%
Effective tax rate
30.32%
ROA
2.60%
ROE
10.92%
D/E
1.18x
Interest coverage ratio
-0.89x

MNK valuation

P/E
P/S
0.00x
P/B
0.00x
P/CF
0.08x
P/FCF
-0.73x
P/OCF
0.08x
PEG
-0.00x
EV multiple
-3.60x

About

Mallinckrodt plc operates as a global pharmaceutical company, engaged in the development, manufacturing, marketing, and distribution of specialized medical products and therapies. Its extensive reach covers the United States, Europe, the Middle East, Africa, and various other international markets. The firm's business operations are segmented into two core divisions: Specialty Brands and Specialty Generics.

Similar securities

Based on sector and market capitalization

Report issue